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The comparative efficacy of different chemotherapeutic regimes in the treatment of
natural clinical infection of Peste des petits ruminants (PPR) infection in West African Dwarf (WAD) goats were determined. Twenty WAD male goats divided into five
groups, of four each were used. Group 1 was the combined therapy group treated with
Acyclovir, Oxytetracycline and Ivermectin, Group 2 was treated with Acyclovir only,
Group 3 was treated with Ivermectin only, Group 4 was treated with Oxytetracycline
only and Group 5 was left untreated. Clinical signs such as nasal and ocular discharges,
emaciation, anorexia, pyrexia, ulcerative oral lesions, respiratory distress and diarrhoea
were observed in these goats during the period of their acclimatization. The prominent
post-mortem lesion observed was discontinuous streaks of congestion (Zebra markings)
in the mucosa of the colon and rectum. The physiologic parameters (temperature, pulse
rate, heart rate, and respiratory rate) were taken daily. It was observed that there was a
significant increase in the temperature above normal in the untreated group, suggesting
pyrexia. It was also observed that the combined therapy group showed a smaller number
of mortality and thus, had a better efficacy when compared to the other chemotherapeutic agents used singly.
Keywords: Peste des petits ruminants, Acyclovir, Oxyteteracycline, Ivermectin, mortality.

Eficacia comparativa de diferentes regímenes
quimioterapéuticos en el tratamiento de la Peste des petits
ruminants (PPR) en cabras enanas de África occidental
Resumen

Se determinó la eficacia comparativa de diferentes regímenes quimioterapéuticos en el
tratamiento de la infección clínica natural con la Peste de los pequeños rumiantes (PPR) en
cabras enanas de África occidental (WAD). Se usaron veinte cabras WAD machos, distribuidas en cinco grupos, de cuatro cabras cada uno. El grupo 1 fue el grupo de terapia
combinada, tratado con aciclovir, oxitetraciclina e ivermectina. El grupo 2 fue tratado
con solo con aciclovir. El grupo 3 fue tratado con ivermectina solamente. El grupo 4
fue tratado con oxitetraciclina y el grupo 5 no recibió tratamiento. Se observaron signos clínicos como secreciones nasales y oculares, emaciación, anorexia, pirexia, lesiones
orales ulcerativas, dificultad respiratoria y diarrea en estas cabras durante su periodo
de aclimatación. La lesión post-mórtem más notable que se observó fueron las manchas
descontinuas de congestión (como las rayas de la cebra) en la mucosa del colon y del
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recto. Los parámetros fisiológicos (temperatura, frecuencia del pulso, ritmo cardiaco y
frecuencia respiratoria) se midieron diariamente. Se observó que había un aumento significativo en la temperatura por encima de lo normal en el grupo sin tratamiento, lo que
sugirió pirexia. También se observó que el grupo de terapia combinada mostró una cifra
de mortalidad menor y, por ende, allí hubo una mejor eficacia en comparación con los
otros agentes quimioterapéuticos usados solos.
Palabras clave: Peste des petits ruminants, aciclovir, oxitetraciclina, ivermectina, mortalidad.

Introduction
Peste des petits ruminants (PPR) is endemic across the
African and Asian continents causing economic and
veterinary important disease leading to considerable
economic losses (1,2). It is known to be endemic in Nigeria as confirmed by Shamaki et al. (3). It is extremely
contagious viral disease of sheep and goats, clinically
manifested by pyrexia, purulent ocular and nasal discharges, dyspnoea, sneezing, pneumonia, ulceration
of mucous membranes of the mouth, gastroenteritis
and severe diarrhoea (4-7). The disease is caused by an
RNA virus, the PPR virus of the Genus Morbilivirus and
the Family Paramyxovirus. Genetic characterization of
the virus has grouped it into four distinct lineages: three
from Africa and one from Asia. One of the African lineages is also found in Asia (8-10). The aetiologic virus
is easily transmitted by direct contact with the aerosols, secretions and/or excretions of infected animals
(2,4,11). PPR is a transboundary animal disease causing enormous economic losses due to the high morbidity and mortality associated with the disease and has
therefore been classified among World Organisation for
Animal Health (OIE) notifiable diseases (12). It poses
a significant threat to the development of livestock production in areas where it is endemic (13,14).
Programs aimed at controlling PPR, have costed farmers, governments and aid agencies so much money.
Hence, this disease remains as a major constraint in the
productivity of small ruminants and is responsible for
severe economic losses according to Ogunsanmi et al.
(15) and Libeau et al. (16). In addition to this, drug de-

velopment provides possible solutions to some tropical
health diseases, although pharmaceutical research is
very exorbitant and a lack of return on investment has
constrained the production of new drugs (17).
Vaccination has been the main method of control but
despite it, sporadic outbreaks have also been reported
by Şevik and Sait (18). In Nigeria, homologous vaccine
for PPR was developed from the attenuation of Nig 75/1
PPRV strain Diallo (19) but recently, Luka et al. (20) reported that Nigerian strains of PPRV demonstrate 9394% homology with PPRV homologous vaccine. Hence,
there is no doubt that it is the vaccine of choice to control the PPR in Nigeria. However, the thermolabile nature of the vaccine may increase the likelihood of low
sero-conversion following vaccination with the vaccine
Sen et al. (21).
Hence this research was conducted to use clinical signs,
Post-mortem lesions and Monoclonal antibody Blocking
ELISA method to serologically diagnose PPR in West
African Dwarf goats and to assess the efficacy of different chemotherapeutic regimens including Acyclovir for
the treatment of PPR in West African Dwarf goats.

Materials and Methods
Study Animals
Twenty WAD male goats, whose ages ranges from six
months to one year with no history of PPR vaccination
adjudged by clinical signs and gross lesions to be
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suffering from natural PPR infection were purchased
from the local markets in Ibagwa and Orba, Nsukka and
Udenu Local Government Area, Enugu State, Nigeria.
The WAD goats were kept together in a well aerated
pen in the Department of Veterinary Surgery, University of Nigeria, Nsukka (UNN) in the experimental animal house unit. They were left to acclimatize for 7 days
(1 week) prior to the commencement of the study.
During this period of acclimatization, the animals were
thoroughly checked for the manifestation of characteristic clinical signs that are suggestive and points to the
scope of the study. Also, during this period, the WAD
goats were fed on (fresh and green) grasses consisting of
Guinea grass (Panicum maximum) and Elephant grass
(Pennisetum purpureum), which is the usual practice in
this eco-zone. Water was also made available ad libitum.

Experimental Drugs and Administration
Chemotherapeutic drugs used include Acyclovir tablet
200 mg (Virest 200®) manufactured by HOVID Bhd.,
Malaysia. It was administered orally (Per.Os) to the animals for 5 days. Oxytetracycline Hydrochloride Short
acting (Oxy-pet®/SA) manufactured by Shanghai Gongyi Vet Medicine Plant, Shanghai (People’s Republic of.
China). It was administered intramuscularly at the dose
of 20 mg of the drug per kg of body weight for five days
and Ivermectin (Kepromec®) manufactured by KEPRO
B.V., Maagdenburgstraat (Holland) was used for treatment at 1ml per 25kg and was administered subcutaneously once in two weeks according to their body weight.
These treatments were instituted from the 7th day, post
infection and based on confirmatory PPR diagnosis.

Experimental Design
Twenty WAD goats were randomly assigned into five
treatment groups – 1, 2, 3, 4 and 5, of four goats per
group. Each goat was duly identified using neck tags:
Group 1- The goats were treated with Acyclovir, Oxytetracycline and Ivermectin; Group 2- The goats were
treated with Acyclovir only; Group 3- The goats were
treated with Ivermectin only; Group 4- The goats were

treated with Oxytetracycline hydrochloride only; and
Group 5- The goats were left untreated.

Experimental Infection
The WAD goats after a period of stabilization and acclimatization were infected by keeping together in a common pen with goats confirmed by haemagglutination
inhibition test and Monoclonal antibody based blocking ELISA to be suffering from PPR infection. This infection was induced according to standard procedures as
described by Ugochukwu et al. (6). Three to five days after, all the animals came down with the infection, showing classical clinical signs of PPR. These animals were
also subjected to Monoclonal antibody-based blocking
ELISA and were all positive for PPR infection.

Blood Sample Collection
Whole blood (2ml) was collected from all experimental animals prior to their separation into groups. This
procedure was aseptically done via the jugular vein by
venipuncture for serology. The blood samples collected were put in sample bottles not containing anticoagulant and could clot and later centrifuged at 3000 rpm
for 15 minutes. The sera obtained were harvested and
stored in a deep freezer prior to the start with the serological analysis.

Physiological Parameters
The major physiological parameters, namely, temperature, pulse rate, heart rate and respiratory rate were
obtained using standard procedures as described by
Chakrabarti (22) and Ugochukwu (6). These physiological parameters were obtained in the mornings
throughout the experiment.

Serological Diagnosis
Monoclonal Antibody-Based Blocking Enzyme-Linked
Immunosorbent Assay was done by the following procedure and using commercially available Enzyme-linked
immunosorbent assay (ELISA) kit (CIRAD-EMVT,
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Montpellier, France) for PPRV. This diagnostic kit detects antibodies directed against the nucleoprotein of
PPRV and was developed by a FAO reference laboratory, CIRAD-EMVT, Montpellier, France. The reaction
was stopped after 10 minutes with 50 μl of 1 M sulphuric acid. Results were read on an ELISA reader at 492
nm. The absorbance was converted to percentage inhibition (PI). Sera showing PI greater than 50% were regarded as positive. This procedure was done according
to standard procedures as described by Saliki et al. (23)
and Munir et al. (24).

Survivability and Clinical Signs
The goats were observed once daily throughout the experimental period for clinical signs of the disease (e.g.,
palpable lymph node, body condition/weight changes,
appetite, mucus membrane colour, ocular discharges,
nasal discharges, etc.) as well as mortality and these
were recorded.

Statistical Analysis
The data obtained were computed into means and analysed using Analysis of Variance (ANOVA). The means
were separated using Duncan’s multiple range tests at
5% level of probability. The results were presented as tables and charts.

Results
Mortality Rate
Table 1 shows the percentage mortality rate of the different groups. Percentage mortality per group was: Group
1, 25%; Group 2, 75%; Group 3, 75%; Group 4, 75%; and
Group 5, 100%. Additionally, Groups 2, 3 and 4 had
comparable mean mortality rates across the groups.

Temperature
Table 2 shows the mean rectal temperature of the different groups. There was no significant difference

(P>0.05) across the groups in week 0 and week 1. In
weeks 2 and 3, Groups 1, 2, 3 and 4 had a comparable
mean temperature and the mean temperatures were
significantly lower than (P<0.05) Group 5 (untreated)
in week 2.
It was observed that the rectal temperatures inthe WAD
goats were within physiological range (38{40oC) in
Groups 1, 2, 3 and 4 throughout the experimental period. Also, Group 5, in weeks 0 and 1, had temperatures
within the physiologic range, but, in week 2, there was
an increase in the temperature value suggesting pyrexia.

Pulse Rate
The mean pulse rates of the different groups are
shown in Table 3. There was no significant differences
(P>0.05) across all the groups in week 0 and week 1. In
week 2, Groups 1, 2, 3 and 4 had a comparable mean
pulse rate and were significantly (P<0.05) higher than
the mean pulse rate for Group 5 (untreated).
In week 3, the mean pulse rate for Group 2 (treated with
Acyclovir only) was significantly (P<0.05) higher than
Group 5 (untreated). Also, there was a significant difference (P<0.05) in Groups 1, 2 and 3 although they had a
comparable mean pulse rate across the groups.
At weeks 0 and 1, the pulse rates across the groups were
within the physiologic range (70-90), except for Groups 2
and 3, in week 0, which had slight increase, but, from week
2 throughout the experimental period, the pulse rates
were higher than normal in Groups 1, 2, 3 and 4. Group 5
showed pulse rate within the normal range in week 1, but
decreased drastically throughout the experiment.

Heart Rate
Table 4 shows the mean heart rate of the different
groups. There was no significant difference (P>0.05)
across the groups in week 0 and week 1. In week 2, there
was a significant increase (P<0.05) in Groups 1, 2, 3 and
4 when compared with Group 5 (untreated) groups.
In week 3, Group 2 (treated with Acyclovir only) was
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Table 1. Survivability and mortality of WAD goats infected naturally with PPR
and treated with different chemotherapeutic regimens
DAY

GROUP 1

GROUP 2

GROUP 3

GROUP 4

GROUP 5

0

0/4

0/4

0/4

0/4

0/4

7

0/4

0/4

0/4

0/4

2/4

11

0/4

2/4

0/4

0/4

3/4

13

0/4

2/4

3/4

0/4

3/4

15

0/4

2/4

3/4

2/4

3/4

17

0/4

3/4

3/4

2/4

3/4

18

1/4

3/4

3/4

2/4

4/4

19

1/4

3/4

3/4

3/4

4/4

Figures represent number of mortality/number of animals in the group
Source: own work

Table 2. Mean±SD of temperature (OC) inWAD goats infected naturally with PPR
and treated with different chemotherapeutic regimens
Week

Group 1 (combined)

Group 2 (Acyclovir)

Group 3 (Ivermectin)

Group 4 (Oxytetracycline)

Group 5 (Untreated)

0

38.33 ± 0.25

38.23 ± 0.32

38.42 ± 0.30

a

37.84 ± 0.16

38.28 ± 0.15a

1

38.58 ± 0.26a

38.07 ± 0.32a

37.86 ± 0.20a

38.44 ± 0.16a

38.29 ± 0.31a

2

38.31 ± 0.20

38.88 ± 0.45

38.89 ± 0.23

38.58 ± 0.27

40.84 ± 0.47b

3

37.65 ± 0.31b

39.60 ± 0.15b

38.50 ± 0.31b

38.25 ± 0.18b

0.00 ± 0.00a

a

a

a

a

a

a

a

Superscripta and b represent the order of significance.
Source: own work

Table 3. Mean ± SD of pulse rates (beats/minute) inWAD goats infected naturally with PPR
and treated with different chemotherapeutic regimens
Week

Group 1 (combined)

Group 2 (Acyclovir)

Group 3 (Ivermectin)

Group 4 (Oxytetracycline)

Group 5 (Untreated)

0

87.71 ± 5.10

93.71 ± 5.10

92.57 ± 5.97

a

89.14 ± 5.08

83.35 ± 5.66a

1

84.86 ± 5.56a

76.86 ± 2.98a

87.24 ± 4.77a

84.66 ± 3.30a

85.43 ± 8.30a

2

95.14 ± 6.47

93.71 ± 4.77

94.86 ± 5.07

103.71 ± 4.91

66.67 ± 10.06a

3

102.50 ± 3.59ab

123.00 ± 18.00b

108.00 ± 8.04ab

112.00 ± 21.17ab

0.00 ± 0.00a

a

b

a

b

a

b

b

Superscripts a and b represent the order of significance.
Source: own work
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significantly higher than (P<0.05) Group 5 (untreated). Also, there was a significant difference (P<0.05) in
Groups 1, 2, 3 and 4 and had a comparable mean heart
rate across the groups.

Respiratory Rate
It was observed that the respiratory rates across the
groups were higher than normal. Normal respiratory
rate ranges from 15cpmto 20cpm. Table 5 shows the
mean respiratory rate in the different groups. In week 0,

Group 5 (untreated) was significantly higher than
(P<0.05) Group 2 (treated with Acyclovir only). Also,
Groups 1, 3 and 4 had a comparable mean respiratory
rate across the groups. In week 1, Group 2 (treated with
Acyclovir only) was significantly higher than (P<0.05)
Group 5 (untreated). Also, Groups 1, 3 and 4 had a comparable mean respiratory rate across the groups. In week 2,
Groups 1, 2, 3 and 4 was significantly higher than
(P<0.05) Group 5 (untreated). In week 3, Groups 1, 2
and 3 was significantly higher than (P<0.05) Group 5
(untreated).

Table 4. Mean±SD of the heart rates (beats/minute) inWAD goats infected naturally with PPR
and treated with different chemotherapeutic regimens
Week

Group 1 (combined)

Group 2 (Acyclovir)

Group 3 (Ivermectin)

Group 4 (Oxytetracycline)

Group 5 (Untreated)

0

95.85 ± 5.20a

106.28 ± 5.31a

108.57 ± 6.70a

99.62 ± 4.40a

101.81 ± 5.57a

1

97.71 ± 4.37

98.28 ± 5.63

100.19 ± 5.94

a

100.14 ± 5.12

86.57 ± 2.92a

2

107.05 ± 10.12b

119.71 ± 8.94b

126.29 ± 9.64b

117.71 ± 4.29b

81.33 ± 4.81a

3

113.00 ± 9.31ab

144.00 ± 6.73b

125.00 ± 5.51ab

120.00 ± 4.32ab

0.00 ± 0.00a

a

a

a

Superscripts a and b represent the order of significance.
Source: own work

Table5. Mean±SD of the respiratory rates (cycles/minute) inWAD goats infected naturally with PPR
and treated with different chemotherapeutic regimens
Week

Group 1 (combined)

Group 2 (Acyclovir)

Group 3 (Ivermectin)

Group 4 (Oxytetracycline)

Group 5 (Untreated)

0

029.90 ± 1.40ab

28.19 ± 1.35a

32.76 ± 1.67ab

31.24 ± 1.45ab

33.52 ± 1.81b

1

31.43 ± 2.63

35.14 ± 1.65

31.90 ± 2.16

ab

33.23 ± 1.46

28.57 ± 2.03a

2

31.19 ± 2.14a

30.29 ± 2.29a

37.14 ± 4.16a

27.57 ± 2.40a

13.14 ± 6.69a

3

32.50 ± 1.71b

30.50 ± 2.99b

34.00 ± 2.58ab

25.00 ± 1.00ab

0.00 ± 0.00a

ab

b

ab

Superscripts a and b represent the order of significance.
Source: own work
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Clinical Signs and Post-Mortem Lesions

ing ulcerative stomatitis, gingivitis and labial Orf-like
lesions as shown in Figure 4.

During the experiment, other clinical signs of PPR were
observed. The clinical signs initially observed were respiratory distress, ocular and nasal discharges as shown
in Figure 1 and 2, lacrimation, pyrexia, dehydration, anorexia and terminally, diarrhoea as shown in Figure 3.
Meanwhile, other clinical signs later developed includ-

Furthermore, some Post-mortem lesions were observed
including oral ulcerative lesions, gastro-enteritis and
the characteristic discontinuous streaks of congestion,
also called Zebra-markings, in the colon and rectum as
shown in Figure 5.

Figure 1. Catarrhal nasal discharges

Figure 2. Ocular discharges

Source: own work

Source: own work
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Figure 4. Labial Orf-like lesions

Figure 3. Diarrhoea (observed at the terminal stage of PPR)

Source: own work

Figure 5. Characteristic discontinuous streaks of congestion
(Zebra-markings) in the mucosa of the colon and rectum

Source: own work

Source: own work
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Discussion
The results from this experiment showed that the mortality rate of West African Dwarf (WAD) goats infected with Peste des petits ruminants without supportive
therapy and/or treatment was high, which is in agreement
with the reports by Kitching, (25) and Jaisree et al. (26).
Clinically, the affected animals showed signs of pyrexia,
anorexia, emaciation, catarrhal nasal discharge, severe
lacrimal and ocular discharges, conjunctival encrustation in the medial canthus ulcerative stomatitis and
severe diarrhoea. These symptoms agree with those described by the FAO (27), Wolhsein and Saliki (28), Islam
et al. (29), Abubakar and Irfan (5) and Ugochukwu et al.
(30) in goats with this disease.
It is also worth noting that the findings from this study
is consistent with the report of Blood et al. (31), who observed that the disease was very fatal in young goats (6080%) especially in the age group of 7-12 months. This
occurrence is observed in Groups 2, 3, 4 and 5, since
these groups showed a mortality rate range between
75%-100%, with the untreated infected PPR goats having 100% mortality rate. This fact agrees with the findings by Dhar et al. (1) and Das et al. (32).
The findings of this experiment are in tandem with the
report by Gupta et al. (33), who reported that broad
spectrum antibiotics (especially Oxytetracycline and
Sulphadimidine) when administered parenterally, have
therapeutic action against PPR infection, which suggests taking preventive measures in terms of vaccination and supportive therapy with oxytetracycline will
help to effectively control the disease.
According to Jackson and Cockcroft (34) and Radostits
et al. (35) the per-rectum temperature was within normal reference values. This is in accordance with the initial findings of this work but, however, later on, there
was a significant increase in the mean temperature in
the untreated group, suggesting pyrexia associated with
the disease as reported by Lefevre and Diallo (36). It
can thus be deduced that the chemotherapeutic agents
(Acyclovir, Oxytetracycline short-acrting Hydrochlo-

ride and Ivermectin) had effects on the treated groups
by stabilizing the temperature to remain within the normal range.
The heart rate, pulse rate and respiratory rate were also
high, deferring from the normal reference values reported by Jackson and Cockcroft (34), Radostits et al., (35),
but this occurrence agrees with the report by Naznin
et al. (37), who reported that the heart rate, pulse rate
and respiratory rate in PPR affected goats are high. It
could be postulated, also, that the significant increase in
the respiratory rate was due to harsh environmental and
weather conditions as well as the presence of the virus.
Ivermectin, a veterinary drug, was incorporated into
the combined treatment regimen to kill internal helminth parasites that were observed in some of the goats
suffering from PPR used in this experiment. It agrees
with findings by Crump and Omura (38). They stated
the efficacy of ivermectin,’’wonder drug’’ against external and internal parasites.
Naznin et al. (37) reported that the recovery rate from
clinical signs was higher in goats treated with parenteral administration of oxytetracycline but as seen in the
findings of this work, it was observed that the combined
therapy using Acyclovir, Oxytetracycline and Ivermectin, had a better efficacy than the other groups treated
singly. The recovery rate of the combined therapy and
the single-Oxytetracycline treated groups were comparable one week post-treatment. It can be deduced
that the Oxytetracycline effects were against bacteria
becoming opportunistic due to the immunosuppressive effects of the virus. It was also postulated that the
combined therapy group also symptomatically combated opportunistic bacterial infection (Oxytetracycline)
as well as the PPR virus (Acyclovir) and parasitic infections (Ivermectin) that may complicate the disease
condition. It provides a platform for rationale for survivability and lower mortality rate in this group.
It was reported by Nawathe (39) that the use of chemotherapeutic agents combined with hygiene, sanitation, isolation, and quarantine of the infected goats had
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positive effects in managing the disease. The present
findings of this work are in agreement with this report.
Also, this work is in tandem with the report by Islam
et al. (2012) and Bupasha et al. (40) who investigated
and reported the efficacy of Oxytetracycline in managing PPR infection.

Conclusions
Acyclovir has not been widely used in PPR cases, but
it is proven in this work that it produced positive efficacy when combined with Oxytetracycline and Ivermectin as palliative or supportive therapy. This in turn,
may allow for immune responses and antibody build up
which might lead to recovery and resistance of the goats
against the virus.
Combination of Acyclovir, Oxytetracycline and Ivermectin is effective in achieving recovery from clinical
signs when compared to the use of these chemotherapeutic agents singly. The presence of the virus had a
significant effect on the temperature, pulse rate and respiratory rate. It also caused high mortality in untreated
PPR infected goats.
A prolonged study should be done to determine the
point of full recovery post-treatment. Although not specific for Paramyxoviruses, it is recommended that more
investigations and assessments should be done on the
use and efficacy of Acyclovir in the treatment of PPR.
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